Trials / Completed
CompletedNCT04596605
Gastrointestinal Tolerance Assessment of T2309
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Laboratoires Thea · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
Gastrointestinal Tolerance assessment of T2309 compared to a food supplement in 50 subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | T2309 | Food for Special Medical Purpose / 4 capsules daily for 12 weeks |
| DIETARY_SUPPLEMENT | Nutrof Total | 2 capsules daily for 12 weeks |
Timeline
- Start date
- 2020-07-15
- Primary completion
- 2021-03-04
- Completion
- 2021-03-04
- First posted
- 2020-10-22
- Last updated
- 2021-07-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04596605. Inclusion in this directory is not an endorsement.